{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16552",
      "entity_text" : "IL-17A",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O00206",
      "entity_text" : "TLR4",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Taken together, the present study demonstrated that EPO may have a critical role against MF by activating PI3K / Akt signaling and by down-regulating TLR4 expression, thereby inhibiting the release of TGF-beta1, TNF-alpha, IL-6, IL-1beta, IL-17A, MMP-9 and MMP-2.",
  "reading_complete" : "2020-08-03T13:51:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:50:51Z",
  "trigger" : "inhibiting",
  "evidence" : [ "TLR4 expression, thereby inhibiting the release of TGF-beta1, TNF-alpha, IL-6, IL-1beta, IL-17A" ],
  "pmc_id" : "6089778",
  "score" : 0
}